Biotechnology

The Aging Proteome: Clocks, Cohorts, and Clinical Trials

In this GEN webinar, two experts will show how ultra-sensitive, multiplexed prot...

ER-Negative Breast Cancer Risk Linked with Blood Levels...

The results of a study found that women with higher blood levels of two common P...

Novartis Confirms Nine Cases of Tumors in Children Trea...

"Two cases to date have shown evidence of vector integration into the DNA of the...

Why Glycosylation Control Is No Longer a Secondary Conc...

A priority shift is redefining expectations for contract development and manufac...

Where DNA Copying Fails Can Decide How Cancer Cells Res...

NYU Grossman School of Medicine researchers found that DNA-copying problems at a...

Boehringer Ingelheim Inks Up-to-$7.4B+ Cancer Drug Coll...

The latest collaboration will encompass six biologic preclinical programs. Five ...

Patient Advocacy Coffee Chat: Basic steps to being a go...

“What does good advocacy look like? Why do we advocate? And what are some tips a...

BIO responds to Health Affairs Analysis, highlighting t...

Orphan drug development is one of the more fraught undertakings in biomedical re...

Modernizing the Western Blot for the 21st Century: More...

Traditional Western blotting can confirm whether a protein is present, but it is...

What Biotech Licensing Really Buys

In this Point of View Sun Chau Siu, PhD, and Kaisong Zhou, PhD, give insights on...

Revealing the Chemistry Around Us Through Mass Spectrom...

Mass spectrometry-based exposomics could be a powerful approach to measuring and...

Beyond the Payload

In this Point of View Anthony Blaszczyk, PhD, principal scientist at USP provide...

Beyond Conventional CRISPR

Genome editing is not designed to replace neurons or retinal cells that have alr...

Oral Sleep Apnea Therapy Poised to Expand Treatment Opt...

An oral obstructive sleep apnea therapy targeting multiple pathways is poised to...

Tissue Engineering Takes Shape

Personalized grafts, bioinks, and off-the-shelf tissues are advancing regenerati...

Orphan Therapeutics Accelerator In-Licenses Its First G...

The nonprofit biotech evaluates potential therapies based on unmet medical need,...